FIELD: medicine.
SUBSTANCE: invention refers to biotechnology, and concerns allele A SNP41 of gene PDE4D, and also its application as a diagnostic marker for estimation of individual propensity for stroke in the Russian population.
EFFECT: invention allows diagnosing propensity for stroke in the Russian population, and enables well-timed and adequate prescription of the required drugs.
4 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF DEVELOPING ISCHEMIC STROKE | 2018 |
|
RU2685859C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING AN ISCHEMIC STROKE, TAKING INTO ACCOUNT GENETIC FACTORS | 2017 |
|
RU2653450C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING AN ISCHEMIC STROKE, TAKING INTO ACCOUNT GENETIC AND MEDIUM FACTORS | 2018 |
|
RU2679635C1 |
METHOD FOR PREDICTING THE RISK OF STROKE IN MEN BASED ON GENETIC TESTING | 2017 |
|
RU2664430C1 |
ALLELE S608L (150S/T) OF GENE NOS2, APPLICATION THEREOF FOR PREDICTION OF COURSE OF ACUTE ATHEROTHROMBOTIC ISCHEMIC STROKE FORMATION, APPLICATION AS MOLECULAR GENETIC MARKER OF INDIVIDUAL CEREBRAL TISSUE SENSITIVITY TO ISCHEMIA AND METHOD FOR PREDICTION OF COURSE OF ACUTE ISCHEMIC ATHEROTHROMBOTIC STROKE | 2010 |
|
RU2423523C1 |
METHOD FOR DETERMINATION OF INDIVIDUAL GENETIC RISK FOR ISCHEMIC STROKE | 2014 |
|
RU2612630C2 |
METHOD FOR DETERMINATION OF GENETIC PREDISPOSITION TO INFECTIVE ENDOCARDITIS | 2016 |
|
RU2618459C1 |
METHOD FOR PREDICTION OF DEVELOPING METABOLIC SYNDROME IN PATIENT SUFFERING ABDOMINAL OBESITY | 2010 |
|
RU2471193C2 |
METHOD OF PROGNOSING DEVELOPMENT OF TYPE 1 SUGAR DIABETES IN POPULATIONS OF BASHKORTOSTAN PEOPLES | 2008 |
|
RU2368325C1 |
METHOD OF DETECTING INDIVIDUAL SUSCEPTIBILITY TO DEVELOPMENT OF VISCEROPATHY IN WORKERS WORKING DUSTY CONDITIONS | 2006 |
|
RU2354972C2 |
Authors
Dates
2011-06-27—Published
2010-04-22—Filed